Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy.
Saved in:
| Title: | Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy. |
|---|---|
| Authors: | Radigan, Rachel1,2 (AUTHOR) rradigan@nyit.edu, Sangal, Ashish3 (AUTHOR), Zhang, Dong2 (AUTHOR), Weber, Jonathan4 (AUTHOR), Schmalzle, Megha1,2 (AUTHOR), Finkelstein, Alexa2 (AUTHOR), Duggal, Vaibhav2 (AUTHOR), Kao, Johnny1,2,3 (AUTHOR) |
| Source: | PLoS ONE. 6/11/2025, Vol. 20 Issue 6, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
